
|Videos|July 28, 2016
Incorporating Newer Antiemetics in Clinical Practice
Advertisement
James Natale, PharmD, BCOP, explains the importance of understanding newer antiemetic options in the changing therapeutic landscape of chemotherapy-induced nausea and vomiting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Notable Updates in Medication Therapy Management in 2025
4
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
5









































































































































































































